Soluble intercellular adhesion molecule 1 (sICAM-1) and malignant melanoma
- 1 August 1993
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 72 (3) , 191-194
- https://doi.org/10.1016/0304-3835(93)90128-v
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Soluble intercellular adhesion molecule-1 levels in patients with psoriasisBritish Journal of Dermatology, 1993
- Circulating Intercellular Adhesion Molecule 1 as a Marker of Disease Progression in Cutaneous MelanomaNew England Journal of Medicine, 1992
- Human epidermal keratinocytes are a source of soluble ICAM-1 molecules*Experimental Dermatology, 1992
- Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disordersThe Lancet, 1991
- Modulation of Melanocyte Intercellular Adhesion Molecule-1 by Immune CytokinesJournal of Investigative Dermatology, 1990
- Recombinant Human Interferon γ: Adverse Effects in High-risk Stage I and II Cutaneous Malignant MelanomaJNCI Journal of the National Cancer Institute, 1990
- Kinetics and characterization of intercellular adhesion molecule-1 (ICAM-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomasJournal of the American Academy of Dermatology, 1989
- Intercellular adhesion molecule-1 (ICAM-1) expression correlated to inflammationBritish Journal of Dermatology, 1989
- Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene familiesCell, 1988
- Phenotypic dynamics of tumor progression in human malignant melanomaInternational Journal of Cancer, 1985